Iba-1, a marker of activation microglia, was widely used to identify immunopositivity microglia in a number of central nervous system disorders, such as Alzheimer's disease [51], schizophrenia and bipolar disorder [52, 53], and spinal cord injury [54, 55]. Here, AIF1 is linked to central nervous system disorder.